Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8211904
APP PUB NO 20070021454A1
SERIAL NO

11487229

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to spiropiperidine compounds of formula (I)

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • MERCK SHARP & DOHME CORP.;SUNESIS PHARMACEUTICALS, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Coburn, Craig A Royersford, US 49 430
Egbertson, Melissa S Ambler, US 29 519
Fahr, Bruce Foster City, US 14 85
Graham, Samuel L Schwenskville, US 57 1066
Lu, Wanli Burlingame, US 6 70
McGaughey, Georgia B Harleysville, US 6 89
Nantermet, Philippe G Lansdale, US 42 384
Rajapakse, Hemaka A Wyncote, US 14 141
Stachel, Shawn J Perkasie, US 38 247
Stauffer, Shaun R Schwenksville, US 45 181
Yang, Wenjin Foster City, US 45 350

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 3, 2024
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00